Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma - McClanahan, Fabienne; Hielscher, Thomas; Neben, Kai; Hillengaß, Jens; Krämer, Alwin; Ho, Anthony Dick; Witzens-Harig, Mathias (American journal of hematology, 2012)
Gesehen am 07.11.2018